More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak ...
Research shows extensive benefits from syringe exchange and other harm reduction programs. But misguided efforts to ban ...
6.0 mg single-dose prefilled syringe for use in the treatment of neovascular or 'wet' age-related macular degeneration, diabetic macular edema and macular edema following retinal vein occlusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback